MFDS designations of 4 additional orphan drugs including lung cancer therapy ‘Brigatinib’
4 medicines, including ‘Brigatinib,’ a targeted therapy for lung cancer, were designated as orphan drug.
The Ministry of Food and Drug Safety(MFDS) pre-announced the ‘Partial Revision Bill to Regulations of Orphan Drugs,’ which newly designated total 4 substances as orphan drug and add and chang...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
